tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Connect Biopharma plans to terminate ADR program, list shares on Nasdaq
PremiumThe FlyConnect Biopharma plans to terminate ADR program, list shares on Nasdaq
20d ago
Connect Biopharma Regains Nasdaq Compliance
Premium
Company Announcements
Connect Biopharma Regains Nasdaq Compliance
24d ago
Connect Biopharma regains Nasdaq compliance
Premium
The Fly
Connect Biopharma regains Nasdaq compliance
24d ago
Connect Biopharma initiated with a Buy at H.C. Wainwright
PremiumThe FlyConnect Biopharma initiated with a Buy at H.C. Wainwright
2M ago
Connect Biopharma files $300M mixed securities shelf
Premium
The Fly
Connect Biopharma files $300M mixed securities shelf
2M ago
Connect Biopharma presents data on Rademikibart at ATS 2025
Premium
The Fly
Connect Biopharma presents data on Rademikibart at ATS 2025
3M ago
Connect Biopharma Launches Phase 2 Asthma Study
PremiumCompany AnnouncementsConnect Biopharma Launches Phase 2 Asthma Study
3M ago
Connect Biopharma initiates Phase 2 Seabreeze STAT Asthma study
Premium
The Fly
Connect Biopharma initiates Phase 2 Seabreeze STAT Asthma study
3M ago
Connect Biopharma Gains FDA Support for Phase 2 Trials
Premium
Company Announcements
Connect Biopharma Gains FDA Support for Phase 2 Trials
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100